KZIA (KZIA) Stock Price & Analysis
KZIA (KZIA) rose 1.23% to USD 12.31 as of September 8, 2026 at 12:47 UTC, according to Nexqual real-time market data.
KZIA last closed at USD 12.31; the session ranged USD 11.77–12.62 on volume of 414,445 shares. Market capitalization is —, with a 52-week range of USD 4.86–17.4 (NCM). Source: Nexqual, September 8, 2026 at 12:47 UTC.
Key Statistics (as of September 8, 2026 at 12:47 UTC)
| Price | USD 12.31 |
|---|---|
| Change | ▲ 1.23% (up) |
| Previous Close | USD 12.31 |
| Open | USD 12.31 |
| Day Range | USD 11.77 – 12.62 |
| 52-Week Range | USD 4.86 – 17.4 |
| Volume | 414,445 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (KZIA)
Nexqual's technical model rates KZIA "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 12:47 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 42.5 (neutral) |
| vs SMA50 | Below (USD 13.33) |
| MACD | -0.12 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| APVO | Aptevo Therapeutics Inc. | USD 1.74 | ▼ 33.08% |
| SNOA | Sonoma Pharmaceuticals, Inc. | USD 1.33 | ▲ 2.71% |
| PHIO | Phio Pharmaceuticals Corp. | USD 1.08 | ▼ 4.42% |
| IMRN | Immuron Limited | USD 1.8 | ▲ 53.85% |
| MNPR | Monopar Therapeutics Inc. | USD 117.56 | ▲ 1.1% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 12:47 UTC. This page is informational and not investment advice.